Time to Next Treatment in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL) Receiving Mogamulizumab or Vorinostat: A MAVORIC Post-Hoc Analysis

Hematological Oncology(2019)

引用 5|浏览5
暂无评分
关键词
mogamulizumab,cutaneous T-cell lymphoma,TCL,T-cell lymphoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要